Metagenics
UltraGI Replenish
LNHPD
26010348
Formula hash
2d90d5e494c0
Catalog
1,340
products
With avoid flag
1
products
FDA recalls
0
history
CAERS
4
reports
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
3
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
Supplement Facts
11 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Biotin vitaminUNII · 6SO6U10H04 3 effects | 75.0 Micrograms | — |
| Vitamin C vitaminUNII · PQ6CK8PD0R UL · set5 effects | 30.0 mg | — |
| Thiamine ThiaminvitaminUNII · X66NSO3N35 3 effects | 0.37 mg | — |
| Isomaltooligosaccharides other | 5.0 g | — |
| Manganese mineralUNII · 42Z2K6ZL8P UL · set2 effects | 1.5 mg | — |
| Pea Protein Pea proteinotherUNII · 7Q50F46595 | 13.0 g | — |
| Riboflavin vitaminUNII · TLM2976OFR 5 effects | 0.42 mg | — |
| Rice Protein otherUNII · J9JP2XE45M | 3.5 g | — |
| Vitamin E vitaminUNII · H4N855PNZ1 UL · set1 effect | 5.0 mg AT | — |
| Vitamin E vitaminUNII · H4N855PNZ1 UL · set1 effect | 7.5 IU | — |
| Niacin vitaminUNII · 2679MF687A UL · set3 effects | 6.7 mg | — |
What this product supports · authorized claims
12 authority-backed effects
Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.
- from: Biotin · Niacin · Riboflavin · Thiamin
- from: Biotin · Niacin · Riboflavin · Thiamin
- from: Thiamin
- from: Riboflavin
- from: Vitamin C
- from: Vitamin C
- from: Vitamin C
- from: Manganese
- from: Manganese
- from: Biotin
- from: Riboflavin · Vitamin C · Vitamin E
- from: Niacin · Riboflavin · Vitamin C
FDA CAERS · adverse event context
3
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →